SCI Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	83.05	60.63	582.38	942.06	166.83	332.23
Trading Asset Securities	1.01	14.17	110.37	89	97.55	360.4
Cash & Short-Term Investments	84.07	74.8	692.76	1,031	264.37	692.63
Cash Growth	-76.56%	-89.20%	-32.81%	290.00%	-61.83%	9.42%
Accounts Receivable	193.22	247.93	289.51	307.37	173.57	82.98
Other Receivables	0.02	1.17	-	0.15	31.1	265.59
Receivables	193.24	249.1	289.51	307.52	204.67	348.56
Inventory	729.71	728.3	620.9	529.53	513.43	294.18
Other Current Assets	56.11	38.23	57.22	85.13	59.93	61.93
Total Current Assets	1,063	1,090	1,660	1,953	1,042	1,397
Property, Plant & Equipment	5,155	5,137	4,803	3,912	3,194	2,100
Long-Term Investments	240.13	187.05	237.52	241.62	208.04	124.97
Other Intangible Assets	25.48	29.65	37.77	46.15	54.58	60.29
Long-Term Deferred Tax Assets	161.56	161.56	143.82	153.28	167.25	241.55
Other Long-Term Assets	280.01	281.26	318.06	384.69	294.11	265.64
Total Assets	6,925	6,887	7,201	6,691	4,961	4,190
Accounts Payable	44.71	60.95	58.44	44.25	48.64	33.78
Accrued Expenses	-	60.3	99.04	110.72	128.35	121.46
Short-Term Debt	315.5	318.6	0.1	175	112	-
Current Portion of Long-Term Debt	145.25	360.11	403.44	20	-	-
Current Portion of Leases	5.7	5.62	2.47	1.95	0.83	1.58
Current Income Taxes Payable	35.49	42.89	85.25	11.54	3.86	-
Current Unearned Revenue	64.36	36.11	94.92	38.37	31.77	41.76
Other Current Liabilities	237.62	151.79	270.73	168.07	444.86	549.35
Total Current Liabilities	848.64	1,036	1,014	569.89	770.32	747.94
Long-Term Debt	574.85	258.39	578.01	842.67	432.36	-
Long-Term Leases	41.86	44.46	6.37	2.86	0.2	0.57
Long-Term Unearned Revenue	-	-	-	-	4.11	-
Pension & Post-Retirement Benefits	-	7.6	11.96	21.54	19.53	16.95
Long-Term Deferred Tax Liabilities	104.52	104.52	104.45	146	103.81	103.81
Other Long-Term Liabilities	45.2	41.02	8.68	7.84	1	-
Total Liabilities	1,615	1,492	1,724	1,591	1,331	869.26
Common Stock	1,195	1,195	1,195	1,195	953.82	953.82
Additional Paid-In Capital	2,245	2,235	2,235	2,234	1,357	1,348
Retained Earnings	1,882	1,968	2,037	1,646	1,373	1,067
Comprehensive Income & Other	-11.91	-3.44	10.07	25.46	-54.73	-48.93
Shareholders' Equity	5,310	5,394	5,477	5,100	3,629	3,321
Total Liabilities & Equity	6,925	6,887	7,201	6,691	4,961	4,190
Total Debt	1,083	987.18	990.39	1,042	545.38	2.16
Net Cash (Debt)	-999.1	-912.39	-297.63	-11.42	-281.01	690.48
Net Cash Growth	-	-	-	-	-	9.52%
Net Cash Per Share	-8.25	-7.62	-2.48	-0.10	-2.61	6.42
Filing Date Shares Outstanding	116.79	119.51	119.51	119.51	107.3	107.3
Total Common Shares Outstanding	116.79	119.51	119.51	119.51	107.3	107.3
Working Capital	214.49	54.05	646.01	1,383	272.08	649.37
Book Value Per Share	45.47	45.14	45.83	42.67	33.82	30.95
Tangible Book Value	5,285	5,365	5,439	5,054	3,575	3,260
Tangible Book Value Per Share	45.25	44.89	45.51	42.29	33.31	30.38
Land	-	687.88	687.88	687.88	687.88	825.68
Buildings	-	723.37	722.9	707	700.23	684.47
Machinery	-	2,510	2,467	1,786	1,185	577.08
Construction In Progress	-	2,452	1,965	1,565	1,323	633.3